Thiol-Activated Furoxan Nitric Oxide Donor–Tyrosine Kinase Inhibitor Hybrids Exploit NRF2-Dependent Redox Vulnerability in Triple-Negative Breast Cancer Cells
Year: 2026
Type: preprint
Source: SSRN Electronic Journal
DOI: 10.2139/ssrn.7369861
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7204858714
